Podcasts about Stipe

Een nieuwe raffinaderij in Beverwijk maakt meststof van zeewier. Het klinkt exotisch, maar is bloedserieus. Holdfast and Stipe komt hiermee met een plantaardig alternatief voor kunstmest.Deze aflevering in het kort:☑️ Waarom zeewier een duurzaam alternatief kan worden voor kunstmest☑️ Hoe boeren hogere opbrengsten kunnen behalen met minder impact☑️ Nog steeds zit er PFAS op onze groenten en fruitIn deze aflevering onderzoeken we de impact van deze innovatie. Die moet een oplossing bieden voor problemen van boeren. Zij moeten vergroenen, maar stuiten op stikstofregels, bodemuitputting en hoge kosten. Holdfast and Stipe biedt ze een 100% plantaardige meststof op basis van zeewier. Gemaakt in een eigen raffinaderij in Beverwijk, zonder chemische bewerking en met een reeks wetenschappelijk onderbouwde voordelen voor gewas, bodem en klimaat.

LIVE FROM ENGLAND w/ TOM ASPINALL!"Mighty" Demetrious Johnson is joined by the UFC interim heavyweight champion Tom Aspinall LIVE from ENGLAND!Timecodes0:00 Intro 1:05 PrizePicks Code MIGHTYCAST 1:51 Welcome Tom Aspinall!  2:00 Tom's Dad is His Coach and Manager 3:13 This Pod was a Long Time Coming… 4:05 This is DJ's First Trip in Europe 4:57 DJ and Tom Linked Up in the Middle of Nowhere 5:55 Tom's Intro to Martial Arts 7:11 Tom's Athletic Background  7:30 Why Tom Gravitated Towards MMA as a Kid 8:26 Tom's First Martial Art 10:26 Tom's Extensive Amateur MMA Career 11:48 The Secret to Tom's Elite Technique  12:49 Tom's Dynamic Movement  14:59 Ridge Code MIGHTYCAST 16:07 Tom's Dad has Always Been His Coach 16:59 Tom Almost Quit MMA?! 18:04 Will Tom Coach His Kids in MMA? (UK Fighter Pay Struggles) 20:27 Why MMA is Great for Young Men 21:10 How to Make GREAT Money in MMA 22:31 Why MMA Fighters Get Taken Advantage of 24:30 Tom's Rise from Amateur to UFC Fighter  25:53 Sparring with Tyson Fury (Go Pro in Boxing) 26:41 How the UFC Discovered Tom/Cage Warriors Rise 28:48 Tom was Hesitant to Join the UFC Contract? 32:15 Tom's Dominant Start to His UFC Career 34:08 Tom's First Main Event Against Volkov in London 35:30 Tom's World Class Heavyweight Gym 36:58 Tom has the Shortest Average Fight Time in UFC History 38:05 Who Runs Tom's Training Camp? 39:51 How Tom Prepares for Fights 41:10 Tom has NEVER Been Past the 1st Round 43:50 Tom's Fighting Mindset  45:57 Should the UFC Ban Weight Cutting? 48:52 Tom is a Natural Heavyweight 49:37 Tom's Big Advantage at Heavyweight 50:23 Pereira vs Aspinall BREAKDOWN 51:59 Fighting at Heavyweight is Easy? 53:43 Tom's In and Out Footwork 55:34 When is Tom vs Jon Jones Happening? 1:02:25 Tom is Leveling Up Big Time Out of Camp  1:03:38 When Does Tom Want to Fight Jones? 1:05:41 How Often Does Tom Spar?  1:07:25 How Often Does Tom Spar?  1:07:52 What is Better: Technical or Hard Sparring?  1:08:26 How Often Does Tom Spar? 1:10:04 Hard Sparring is Not Worth It… 1:13:42 Tom's Hilarious YouTube Channel 1:16:41 Tom Trains with Eddie Hall 1:19:19 Could DJ Beat Eddie Hall in MMA? 1:20:03 How Tom Spent His First Big Check 1:22:33 How Tom Spent His Last Big Check 1:23:38 How to Support Tom  1:24:31 Why Hasn't Tom vs Jon Jones Happened? 1:27:29 Stipe vs Jones Shouldn't Have Happened? 1:28:59 Tom's New Deal with Champion  1:29:42 DJ Gives Tom His Flowers  1:32:06 MightyRecap! 1:32:22 Tom is Such a Nice Guy 1:33:02 DJ Loves that Tom's Dad is His Coach 1:33:18 Tom's Movement Breakdown 1:33:56 The UFC is Doing Tom Dirty with the Jones Fight… 1:35:07 Jones vs Tom BREAKDOWN 1:36:45 Why Hasn't Jones vs Tom Happened?  1:38:19 Is Jones Ducking Tom?! 1:39:06 Stipe vs Jones Should Not Have Happened? 1:42:04 Jon Jones is Doing Everything on Purpose?  1:42:46 SIGNED DJ AND TOM GLOVE GIVEAWAY!! 1:43:33 Will Tom vs Jones Happen? 1:44:30 Is Jones Still the GOAT if He Ducks Aspinall?  1:47:10 Can the UFC Please Promote Fights Again  1:48:02 Tom Can Be a SuperstarProduced/edited by Michael Wonsover (@mwonsover on IG/Twitter)Edited by Nick Pappas (@nick_pappas44 on IG)⚡️1st Phorm

Send the show a text message!In this episode of the Space Between podcast, host Renae Lipsmeyer interviews Jennifer Stipe, who shares her unique journey as a fan of the Dave Matthews Band. From her gardening adventures to starting a business during challenging times, Jennie reflects on how music has shaped her life and provided a sense of community. She recounts her early experiences with the band, the impact of their music on her personal growth, and the connections she formed with others who share her passion for the band. The conversation highlights the transformative power of music and the importance of taking chances in life. Jennie shares her profound connection to the Dave Matthews Band, detailing how their music served as a lifeline during her turbulent teenage years marked by addiction and family struggles. She recounts her journey to see the band live, the emotional significance of their concerts, and a pivotal moment when she received a tattoo drawn by Dave Matthews himself, symbolizing her gratitude for the impact his music had on her life. Jennifer Stipe reflects on the surreal moment of meeting her hero, the impact of music during challenging times, and the importance of community and vulnerability in sharing personal stories. The discussion also touches on the science behind music and its therapeutic effects on mental health, emphasizing how music can serve as a powerful tool for healing and connection.#DMB #davematthewsband #podcast  Support the show

In this episode of Omni Talk's Ask an Expert series, Chris Walton and Anne Mezzenga talk with Stipe Galic, VP of Business Development & Marketing at TGW, to demystify the complexities of returns in today's omnichannel retail world. From cost savings to faster reshelving, Stipe walks us through how automation, flexible software, and a unified DC setup are transforming how retailers like Urban Outfitters manage inventory and returns. Key Moments: 1:05 – Stipe's journey from mechanical engineer to automation leader at TGW 4:59 – Why returns are such a thorn in omnichannel fulfillment 7:00 – Real-time processing of returns with mixed-SKU totes 10:00 – How software decides between single-SKU and return stock 14:36 – Case study: High-end fashion retailer consolidating DC operations 19:56 – Cutting return costs nearly in half through automation 22:00 – “Bridge vs. Ferry” analogy on warehouse responsiveness 24:35 – Seamless integration > cutting-edge tech: the new mindset Music by hooksounds.com *Sponsored Content*

She played Danny's equal when it came to all things cleanliness... It's Debra Stipe, aka Cindy! Did you know that originally, Cindy and Danny were supposed to get married?! Debra tells us exactly why she turned down the opportunity... Let's just say, we would've been rooting for a Danny + Cindy marriage!! Hear all about Debra's experience on set and what it was like working with the Full House cast and crew! It's all right here on How Rude, Tanneritos! See omnystudio.com/listener for privacy information.

In 1948, at the age of 21, Gene Stipe was elected to the Oklahoma State House of Representatives representing Pittsburgh County, making him the youngest person elected to the state legislature. Stipe won a senate seat in 1956 and served for forty-eight years, making him the longest-serving Oklahoma State Senator.   Gene had a reputation as an excellent trial lawyer and took the lead in some important Oklahoma court cases.On January 1st, 2000, Gene published the book A Gathering of Heroes, featuring stories of many Oklahomans. Some of the heroes he talked about included former U.S. Senator Robert Kerr, Judge Luther Bohanon, and Lloyd Rader.The book is still available on Amazon.  Gene Stipe was 85 when he died on July 21st, 2012.When John Erling was with KRMG radio, he interviewed Gene about the book in 2000, and you can hear the interview now on the podcast and oral history website VoicesOfOklahoma.com.

In this episode, I recap UFC 309 Jones vs Stipe. I talk about comments Aspinall has made and how it impacts Jon's next fight. I talk about Oliveira's next fight and Topuria's potential move to 155. I recap Figeurido vs Yan and how it can lead to Yan O'Malley 2 and Pantoja Figeurido 2 with the announcement of Umar vs Merab. I recap Pantoja vs Asakura and discuss the results of Shavkat vs Ian with Shavkat's potential injury and how that impacts Belal's next fight. I also give my predictions for Covington vs Buckley.

R.E.M. considered themselves missionaries against the prevailing pop culture – no solos, no old-school stagecraft, no printed lyrics, no lip-syncing, no hard-sell videos, no obvious leader – and mapped out a whole new route to international success. Peter Ames Carlin, whose books include biographies of Springsteen, Brian Wilson and Paul Simon, talks to us here about ‘The Name of this Band is R.E.M.', what they pioneered and how it rearranged the rock and roll furniture. Which involves … … why their Letterman Show was a statement of intent. … “rather than bending to the mainstream, they did what they wanted ‘til the mainstream bent to them.” … where you can see “the R.E.M. model” - from Sleater-Kinney to Taylor Swift. … when ‘Mike Stipe' became Michael. … Stipe's first TV appearance, dressed as Frank-N-Furter at a Rocky Horror Show screening. … why rock critics connected with them.  … the strategies they share with U2, Radiohead and Coldplay.  … “Springsteen = Elvis + Dylan”. … what was in the water in Athens, Georgia, that produced such unconventionalacts - R.E.M., the B-52's, Pylon, Love Tractor. … their ‘straight' but supportive parents – Stipe's dad in the military, Mills' dad a marine helicopter pilot. … how R.E.M. “channelled popular culture”. … their pioneering approach to record deals, royalties, videos, mixing and song-writing. … and which of them most wants a reunion. Order ‘The Name Of This Band Is R.E.M.' here:https://www.amazon.co.uk/Name-This-Band-M-Biography/dp/0385546947Find out more about how to help us to keep the conversation going: https://www.patreon.com/wordinyourear Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

R.E.M. considered themselves missionaries against the prevailing pop culture – no solos, no old-school stagecraft, no printed lyrics, no lip-syncing, no hard-sell videos, no obvious leader – and mapped out a whole new route to international success. Peter Ames Carlin, whose books include biographies of Springsteen, Brian Wilson and Paul Simon, talks to us here about ‘The Name of this Band is R.E.M.', what they pioneered and how it rearranged the rock and roll furniture. Which involves … … why their Letterman Show was a statement of intent. … “rather than bending to the mainstream, they did what they wanted ‘til the mainstream bent to them.” … where you can see “the R.E.M. model” - from Sleater-Kinney to Taylor Swift. … when ‘Mike Stipe' became Michael. … Stipe's first TV appearance, dressed as Frank-N-Furter at a Rocky Horror Show screening. … why rock critics connected with them.  … the strategies they share with U2, Radiohead and Coldplay.  … “Springsteen = Elvis + Dylan”. … what was in the water in Athens, Georgia, that produced such unconventionalacts - R.E.M., the B-52's, Pylon, Love Tractor. … their ‘straight' but supportive parents – Stipe's dad in the military, Mills' dad a marine helicopter pilot. … how R.E.M. “channelled popular culture”. … their pioneering approach to record deals, royalties, videos, mixing and song-writing. … and which of them most wants a reunion. Order ‘The Name Of This Band Is R.E.M.' here:https://www.amazon.co.uk/Name-This-Band-M-Biography/dp/0385546947Find out more about how to help us to keep the conversation going: https://www.patreon.com/wordinyourear Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

R.E.M. considered themselves missionaries against the prevailing pop culture – no solos, no old-school stagecraft, no printed lyrics, no lip-syncing, no hard-sell videos, no obvious leader – and mapped out a whole new route to international success. Peter Ames Carlin, whose books include biographies of Springsteen, Brian Wilson and Paul Simon, talks to us here about ‘The Name of this Band is R.E.M.', what they pioneered and how it rearranged the rock and roll furniture. Which involves … … why their Letterman Show was a statement of intent. … “rather than bending to the mainstream, they did what they wanted ‘til the mainstream bent to them.” … where you can see “the R.E.M. model” - from Sleater-Kinney to Taylor Swift. … when ‘Mike Stipe' became Michael. … Stipe's first TV appearance, dressed as Frank-N-Furter at a Rocky Horror Show screening. … why rock critics connected with them.  … the strategies they share with U2, Radiohead and Coldplay.  … “Springsteen = Elvis + Dylan”. … what was in the water in Athens, Georgia, that produced such unconventionalacts - R.E.M., the B-52's, Pylon, Love Tractor. … their ‘straight' but supportive parents – Stipe's dad in the military, Mills' dad a marine helicopter pilot. … how R.E.M. “channelled popular culture”. … their pioneering approach to record deals, royalties, videos, mixing and song-writing. … and which of them most wants a reunion. Order ‘The Name Of This Band Is R.E.M.' here:https://www.amazon.co.uk/Name-This-Band-M-Biography/dp/0385546947Find out more about how to help us to keep the conversation going: https://www.patreon.com/wordinyourear Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information.

MARCUS IS BACK!Sub to Marcus YouTube!  @Marcus_Maniac_McGhee  Follow Marcus on IG @maniac_mcgheemmaOn this week's episode of the Red Hawk Recap, Tim “The Red Hawk” Welch is joined by Joe Diesel Riggs and fresh off his huge win at UFC 309, the #14 ranked bantamweight in the world, Marcus McGhee! The boys go deep on Marcus' Big Win, who's next, Jones vs Stipe, is Jon Jones ducking Tom Aspinall, Mike Tyson vs Jake Paul and more!♠️ Check out Spade! Use Code: TIMBOSPADE10 FOR 10% OFF!!https://www.amazon.com/stores/SPADE/page/91C86242-444D-487E-9D63-3FBB1503187F?ref_=ast_blnTimestamps:0:00 Intro0:29 Spade! CODE TIMBOSPADE10!1:11 Tyson vs Paul Trip Recap3:26 UFC on Netflix Next Year?!4:14 Marcus' BIG WIN Over Jonathan Martinez at UFC 309!6:57 Calf Kicks Hurt SO Bad…8:18 How Marcus Survived the Final 2 Minutes vs Martinez9:25 How to Stay Composed in a Fight11:15 Marcus' Walk Around Wait (BIG 135er)14:22 Weight Cutting Used to Be SKETCHY15:41 Does Weight Cutting Impact Your Chin?16:30 Weight Cuts are BRUTAL/Proper Weight Cutting17:46 Tim's Problem with the UFC…18:03 The Boys Spark Up!18:56 Marcus is OFFICIALLY Ranked19:48 Does Marcus Let His Kids Watch His Fights?20:08 Riggs Set Marcus Up?!(Local Fights)21:08 Joe Peed on People's Feet After Fights?!21:30 Who is Next for Marcus?!25:43 Don't Shield Your Kids from the World…26:47 Addiction in Marcus' Family28:41 Are Fathers or Mothers More Important for Kids?29:46 Is it Better for Unhappy Parents to Stay Together?31:52 Relationships are SO Hard32:46 Can Bo Nickal Beat Khamzat?!36:49 Oliveira vs Chandler BREAKDOWN38:41 Jones vs Stipe BREAKDOWN39:37 The Hardest Hitting Shot in MMA41:01 Jones vs Aspinall WHO Wins?!42:02 Will Jones Fight Aspinall?44:52 Crazy NFL vs UFC Reveune Stats47:50 Crypto is PUMPIN Right Now…49:00 Marcus & Tim Buying Food Trucks?49:55 The Boys Craziest Street Fight Stories56:42 Marcus' Unique Recovery Routine58:57 Elite MMA Athletes 59:10 Marcus is JACKED1:00:21 Marcus Teaches the Boys Wing Chun

On episode 200, the boys talk about Tyson vs Paul and Jones vs Stipe. They dive into the latest films they watched. Zeke's 5th birthday and Renato's cooking.

Week 11 NFL discussion. Who is the best team after week 11? We also discuss NBA news and Jon Jones defending his heavyweight title against Stipe and cementing his GOAT status

MMA GURU IS BACK! On the latest episode of "MightyCast", Demetrious Johnson is joined by the one & only MMA Guru to recap UFC 309, Jones vs Aspinall, & more! Timestamps Timestamps 0:00 Intro   0:52 PrizePicks CODE MIGHTYCAST!   1:32 Welcome MMA Guru!   2:31 MMA Guru is an ELITE Detective   3:54 Jones vs Stipe REACTION   6:24 Guru is Happy Jones Didn't Fight Aspinall?   9:31 DoorDash CODE MIGHTY 2024!   10:28 VIIA HEMP CODE MIGHTY!   11:45 Stipe's Performance Against Jones   12:32 Is Jones Ducking Aspinall?   16:46 Why Does Dana Glaze Jon SO Much?   18:00 Jon HAS TO Fight Aspinall Next?   22:07 The Heavyweight Division is BAD…   24:54 Guru's HOT TAKE on Jones Positive Steroid Tests   26:30 What to Do if Jones Won't Fight Aspinall   27:16 Rico Verhoeven to the UFC?!   29:17 Guru's HOT TAKE on Jones Positive Steroid Tests PT. 2   31:19 DJ's Take on Jon's Positive Steroid Tests   33:50 Who is Guru's GOAT of MMA   35:35 Deep Dive into Jones' Positive Tests   37:13 UFC Stars Failing Drug Tests   44:24 Fans Forget Fighters Used to be JUICED UP…   48:06 UFC Stars Failing Drug Tests PT. 2   52:05 The UFC is Going After Guru?   54:26 The Secret to Guru's YouTube Success   54:58 Oliveira vs Chandler BREAKDOWN   56:23 Chandler Cheated Against Charles?!   58:20 Chandler vs McGregor BREAKDOWN   58:41 Chandler's NEW Fight Style   1:02:16 Who is Next for Oliveira/Chandler?   1:07:53 Chandler vs Holloway Next?!   1:08:26 Tyson vs Paul/Till vs Fury REACTION   1:09:38 Jake Needs to Fight a REAL Opponent…   1:12:05 Where to Follow Guru(He's a Decent Guy)   1:13:29 MightyRecap!   1:13:40 DJ's Reaction to Jon's Failed Tests   1:14:55 What DJ Wants Next for Jones/Pereira/Aspinall   1:21:02 What Deems a Fighter as “The Goat”   1:24:56 Will Jones vs Aspinall Happen? Produced/Edited by Michael Wonsover (@mwonsover on IG/Twitter) Edited by Nick Pappas (@nick_pappas44 on IG) ⚡️ PrizePicks: Sign up with code "MIGHTYCAST" to play $5 and WIN $50 INSTANTLY https://prizepicks.onelink.me/ivHR/MIGHTYCAST If you're +21, try VIIA Hemp today and use code MIGHTY to save 15% https://bit.ly/viiamighty ⚡️ 1st Phorm: Check out 1st Phorm at https://1stphorm.com/mightycast ★ Merch: https://shopmighty.com ♦ Twitter: https://twitter.com/mightymouse/ ♦ Instagram: https://www.instagram.com/mighty/ ♦ Discord: https://discord.gg/mightysquad ♦ My Quantum Bars: https://quantumsquares.com/ Promo Code: MIGHTYGAMING10 ♦ My Cold Therapy: https://icebarrel.com/ Promo Code: MIGHTY

Liga Combate en las redes sociales: Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.twitter.com/ericaiexander⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Segundo Canal:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UC4o9ZJOU60cS984XcgHndPA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.instagram.com/ericalexander.mma⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/LigaCombate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Whatsapp: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://whatsapp.com/channel/0029VaBIOBU8PgsEAWx47h0U⁠ --- Support this podcast: https://podcasters.spotify.com/pod/show/conexionmma/support

Brendan Schaub recaps UFC 309 Jon Jones vs Stipe Miocic, Jake Paul vs Mike Tyson and Gamebred BKMMA 8 and talks people calling Jake Pauls fake, Stipe looking like he didn't even want to fight, how Jon Jones being undefeated for this long is the most impressive thing in all of sports, however, he's not sure if this version of Jones can beat Tom Aspinall, and how Tom will never be the greatest if Jon retires. Also, current events including Mikey Musumeci signing with the UFC, Nick Diaz out of his fight with Vicente Luque, Tommy Fury vs Darren Till in boxing, Kron Gracie vs Bryce MItchell, Ian Machado vs Shavkat Rakhmonov, Colby Covington vs Joaquin Buckley and much more. Magnesium Breakthrough by BIOptimizers - Head over to bioptimizers.com/schaub and enter code Schaub at checkout to get discounts plus access to up to $100 in free gifts with purchase. DraftKings - Download the DraftKings Sportsbook app NOW and use code SCHAUBSHOW O'Reilly - http://oreillyauto.com/SCHAUB Progressive - https://www.progressive.com/ Sure Shot - https://sureshot.com/

What a wild weekend it was and MK is here to break it all down for you. BC and Luke are back in studio and kick-off the show by talking all things UFC 309. In the main event, Jon Jones made a dominant return from injury/layoff to retire Stipe Miocic via TKO3. In just his 2nd fight in 5 years and first in 18 months following surgery, Jones looked like a complete heavyweight threat. In what ways did BONY's destruction of Miocic add to his already GOAT-plated legacy?  After his destruction of Stipe, Jon Jones said he wants "f**k you money" to fight Tom Aspinall, but still prefers theAlex Pereira fight. From all of the fight week rherotic to Jones' post-fight reaction, do you now believe he will fight Tom Aspinall next and that the UFC pay him handsomely enough to accept it? In the co-main event, Charles Oliveira held off a furious Michael Chandler rally to secure possible title shot. At 35, how much of a threat does Charles Oliveira still appear to be in terms of regaining the UFC lightweight title?  Moving on to UFC 310, Luke and Brian react to the new card announcement, following Belal Muhammad's withdrawal and UFC's late replacements.And of course, we can't forget the boxing fight of the year as Jake Paul outpointed Mike Tyson in pointless, record-breaking Netflix main event. While it's easy for everyone to ask, in hindsight, "what did you expect" from a YouTuber and a 58-year-old, how much of a stain was it for boxing given the 65 million households watching globally that Tyson-Paul turned out to be nothing more than a scripted exhibition between friends? Given the controversy of Taylor-Serrano rematch, is there a market for a trilogy fight?  Learn more about your ad choices. Visit megaphone.fm/adchoicesSee omnystudio.com/listener for privacy information.

What a wild weekend it was and MK is here to break it all down for you. BC and Luke are back in studio and kick-off the show by talking all things UFC 309. In the main event, Jon Jones made a dominant return from injury/layoff to retire Stipe Miocic via TKO3. In just his 2nd fight in 5 years and first in 18 months following surgery, Jones looked like a complete heavyweight threat. In what ways did BONY's destruction of Miocic add to his already GOAT-plated legacy?   After his destruction of Stipe, Jon Jones said he wants "f**k you money" to fight Tom Aspinall, but still prefers theAlex Pereira fight. From all of the fight week rherotic to Jones' post-fight reaction, do you now believe he will fight Tom Aspinall next and that the UFC pay him handsomely enough to accept it? In the co-main event, Charles Oliveira held off a furious Michael Chandler rally to secure possible title shot. At 35, how much of a threat does Charles Oliveira still appear to be in terms of regaining the UFC lightweight title?   Moving on to UFC 310, Luke and Brian react to the new card announcement, following Belal Muhammad's withdrawal and UFC's late replacements. And of course, we can't forget the boxing fight of the year as Jake Paul outpointed Mike Tyson in pointless, record-breaking Netflix main event. While it's easy for everyone to ask, in hindsight, "what did you expect" from a YouTuber and a 58-year-old, how much of a stain was it for boxing given the 65 million households watching globally that Tyson-Paul turned out to be nothing more than a scripted exhibition between friends? Given the controversy of Taylor-Serrano rematch, is there a market for a trilogy fight?  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sean and Graeme talk Jones vs. Stipe, Aspinall's shadow over the week, James Webb, KSW, Ian Garry and more! Patreon.com/SevereMMAPodcast And now….. here's the podcast!

Im a huge fight fan, and this was one hell of a fight weekend, with Tyson vs Paul and Jon Jones vs Stipe, although tbh, the real standout of the weekend was Taylor vs Serrano. But something was really different about the whole thing. Rather than be all about the fights, politics were all over the place. So what does it all mean? and wth is happening with Twitch? Don't stress, let's look over the fight tape together. I got you covered, with Janaya Future Khan.

In this episode, I give my predictions for UFC 309 Jones vs Stipe. I also give a prediction of the UFC still looking at Pereira Jones with a potential faceoff opportunity tonight as a huge promo for it if Jones calls out pereira again.

Join me as I review UFC 309 from a totals perspective. We review every total on the board and discuss the betting lines for each of them. Clint will provide his leans for betting over or under and try to give you an alternate way to bet the fight if you cant pick a side!Premium Home of Fight Bets on Winnable: https://www.winible.com/checkout/1363223394291568749?store_url=/hofpicks&a=7B0B14&interval=Week Promo Code: 309 for a 5 day free trial*Bet Openly*: https://app.betopenly.com/?s=dhmFight Numbers DFS & Betting Tools: https://t.co/4wymvWC47oJoin Nuke The House for incredible sports betting results across all sportshttps://nukethehouse.com/Promo Code: CLINT for a FREE WEEKNew Die Hard MMA Merch!!Check out the shop! https://die-hard-mma-podcast-merch.myspreadshop.com/allFollow Spectation Sports @SpectationNet for Regional MMAPromo Code: DIEHARD for 20% off your subscription https://spectationlink.com/DIEHARD

Welcome back to Lawn Chair Sports. This week the boys discuss a great weekend for fights. Jake Paul vs. Mike Tyson and Stipe vs. Jones. Shoutout to the Bold Gold Antelopes. They also make their week 11 predictions. Follow Samuel Douglas : https://www.instagram.com/thesamueldouglas/Follow Leezy Lee : https://www.instagram.com/leezylee23/Follow The Snake Pit : https://www.instagram.com/thesnakepitpodcast_/s

UFC 309: Jones vs Stipe, Tyson vs Paul Boxing, Recap of last few weeks of Fights and LFA event review

The boys are back w/  @comedianromeomac  as they give their UFC 309 Jon Jones vs Stipe Miocic Picks & Predictions. We break down this Madison Square Garden card headlined by Jon Jones & Stipe. As we make the picks on all the fights, Paul will give out some of the bets he is hammering this weekend. As always Pour up, spark up & Enjoy the Breakdown of UFC.

Jaxxon Podcast Presented by Jaxxon Jewelry. Shop the best Men's chains

UFC 309 is finally here! DC and Chael are back talking Jones and Miocic. So has DC seen Jon Jones? Hear why it involves one of them taking a walk. Does Jones dismissing Tom Aspinall taint his legacy? Chael is all in on the new look Stipe, but can he get it done against the greatest to ever do it? See what Chael has to say. Michael Chandler returns to the octagon and hear who DC compares him too. It may surprise you. Plus, what's at stake for Charles Oliveira. And, the guys chat about undefeated rising star Bo Nickal.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

BOYS ONLY EPISODE!On this week's episode of the Red Hawk Recap, Tim “The Red Hawk” Welch is joined by Joe Diesel Riggs and Warlike. The boys go deep on Jones vs Stipe, is Jon Jones ducking Tom Aspinall, Mike Tyson's tough open workout, Chandler vs Oliveira and more!⚡️Check out PrizePicks! Click here: https://prizepicks.onelink.me/ivHR/TIMBO and use the code "TIMBO" for a 100% Deposit Match Up to $100♠️ Check out Spade! Use Code: TIMBOSPADE10 FOR 10% OFF!!https://www.amazon.com/stores/SPADE/page/91C86242-444D-487E-9D63-3FBB1503187F?ref_=ast_blnTimestamps:0:00 Intro0:30 PrizePicks! 1:06 Warlike and Tim's Bet2:01 Riggs Corned at the UFC Fights3:06 Riggs Ran into Mackenzie Dern4:27 Joe Started “Microdosing”5:13 Joe Got Kicked Off a Plane?!7:49 Joe Got Baked All Fight Week8:47 Carlos Prates is a BEAST9:33 The Best Way to Do Shrooms (Joe's Bad Trip)11:19 Bo Nickal vs Paul Craig BREAKDOWN13:40 Marcus McGhee vs Jonathtan Martinez BREAKDOWN15:27 Charles Oliveira vs Michael Chandler BREAKDOWN17:31 Jon Jones vs Stipe Miocic BREAKDOWN19:23 Jones is DUCKING Aspinall?!20:35 Matt Hamill on Beating Jon Jones20:59 The Boys are Going to Tyson vs Paul27:28 Elon Musk's DOGE28:27 Crypto is BOOMING29:03 Unwritten BJJ Rules For White Belts30:33 Why Does Warlike Think He is the Next MMA Guru?31:30 Would Riggs Assault Warlike?31:52 Post Nut Clarity Stories34:07 What is More Important Endurance or Strength?35:35 Advice for Kickboxing Tournament36:58 Riggs Family Update 39:14 Would Tim Let Schmitty Get Jumped?39:41 Tim vs Coyotes42:34 Tim is Doing Some Cat Shopping46:47 RFK Jr. vs the FDA48:44 Tommy Got a Fight!51:04 If the Boys Went to College What Would It Be For?52:55 Joe is Working on His Stutter53:48 Figuerdo vs Yan BREAKDOWN!54:51 Mike Tyson is in Trouble…

Watch the episode on YouTube - https://www.youtube.com/watch?v=2aioWoXHLe8 Follow The BradyBagz Show On Instagram: https://www.instagram.com/thebradybagzshow/ Learn more about SteadyPicks: https://www.steadypicks.com/

The boys catch up and chat all things sport on this episode! AFL "opening round" has been announced, should there be some bigger games to open up the AFL season for 2025? Robbo and Matho delve into AFLW having a horrible fixture, wtf is Dusty Martin doing with Fox Footy big dogs and it's a huge week for combat sports with Tyson vs Jake Paul, Jon Jones vs Stipe!

On this episode of The MMA Roasted Podcast, the gang previews Tyson vs. Paul and Jones vs. Stipe! You do NOT want to miss this one! GAME TIME! Take the guesswork of buying tickets with GAMETIME! Download the Gametime app, create an account, and use the code CLNS for $20 off your first purchase! Download Gametime TODAY! Learn more about your ad choices. Visit megaphone.fm/adchoices

 In today's episode, Fares and Josh dive into the highly anticipated UFC 309 card for Saturday, November 16. Headlining the event is one of the sport's all-time greats, Jon Jones, defending his crown against the most decorated heavyweight ever, Stipe Miocic (3:44). Then, we break down the fire in the co-main event rematch, with Charles Oliveira looking to bounce back against Michael Chandler (18:52) HBP MERCHHBP IG https://www.instagram.com/thehbpod_/

Michael Bisping and Anthony Smith discuss everything UFC 309 from previews and predictions for every fight on the main card, all the biggest stories going into fight week including Jon Jones talking retirement or Periera if he gets past Stipe, what to expect out of Michael Chandler after his long layoff and more plus a look at Tyson vs Paul on Friday night, Carlos Prates dismantling Neil Magny inside of a round then calling for a top-ranked opponent plus so much more! This Episode Was Recorded On 11.11.24 Follow the show on social media: Twitter: https://twitter.com/BYMPod Subscribe on YouTube: https://bit.ly/3drq6ps Follow the hosts on social: Michael Bisping Twitter https://twitter.com/bisping Michael Bisping Instagram https://www.instagram.com/mikebisping/ Michael Bisping YouTube https://www.youtube.com/channel/UCDrG2_1TcVkXKXXsD6Kjwig Website https://gasdigitalnetwork.com/gdn-show-channels/believe-you-me/ Anthony Smith Twitter: https://twitter.com/lionheartasmith Anthony Smith Instagram: https://www.instagram.com/lionheartasmith/ Mike's debut book "Quitters Never Win" is available wherever books are sold, click here to get a copy! https://bit.ly/2V9ZqDk Follow the team on social: Brian MacKay Instagram: https://www.instagram.com/bmackayisright Brian MacKay Twitter: https://twitter.com/bmackayisright Mike Harrington Twitter: https://twitter.com/TheMHarrington Mike Harrington Instagram https://www.instagram.com/themharrington Mike Harrington YouTube: https://www.youtube.com/@themharrington Learn more about your ad choices. Visit megaphone.fm/adchoices

Luke Thomas helps preview the big Jon Jones return at UFC 309! What's Stipe's path to victory, is there one? Is Jones ducking Aspinall? Will Pereira really be next? What's Chander/Oliveira 2 gonna look like, is Bo Nickal ready for the deep end of 185 and more! Subscribe to Luke's channel and tune in for his live watch along! https://www.youtube.com/@UC2EuJ9xTs0XkDZI9YGx7QZA IF YOU WANT TO SUPPORT PLEASE SUBSCRIBE TO THE CHANNEL: http://bit.ly/2arsrDN Download the Saily app and use the code [submission] or go to https://Saily.com/submission to get an exclusive 15% off your first purchase. Don't forget to use code "SUBMISSION" at https://Manscaped.com for 20% AND FREE SHIPPING (Plus you're helping the show)  Get THE BEST VPN, NORDVPN TODAY! Get 4 months free and a special offer now: https://Nordpn.com/Submission   

MICHAEL CHANDLER IS BACK! On the latest episode of "MightyCast", Demetrious Johnson is joined by the one & only "Iron" Michael Chander ahead of his UFC 309 co-main event vs Charles Oliveira! ⚡️ Upgrade your wardrobe and save on @trueclassic at trueclassic.com/MIGHTY ! #trueclassicpod ⚡️ Go to BetterHelp.com/MIGHTYCAST to save 10% on your first month! ⚡️ PrizePicks: Sign up with code "MIGHTYCAST" to play $5 and WIN $50 INSTANTLY https://prizepicks.onelink.me/ivHR/MIGHTYCAST Timestamps 0:00 Intro 1:03 PrizePicks! 1:52 Welcome Michael Chandler! 2:16 Chandler has a Skin Care Routine?! (DJ's Secret Skincare) 4:24 Chandler vs Eddie Alvarez was a BANGER 7:30 Chandler's was VERY Active Before McGregor 9:22 Why Did Chandler Leave Bellator? 11:51 Better Help! 13:17 True Classic Tees! 16:17 Taking 2 Years Off Waiting for McGregor 21:55 Will Conor McGregor Ever Fight Again? 24:22 2 Years Off Helped Chandler? 26:44 Chandler's UNIQUE Strength and Conditioning Routine 33:48 Why Does Chandler Get Tired in Fights? 37:21 Chandler's Legendary Work Ethic 42:39 Tyron Woodley and Ben Askren Changed Chandler's Life 46:46 The KEY to DJ and Chandler's MMA Success 47:50 Chandler Told Paddy to Stop Getting Fat? 50:38 How to Create a Strong Work Ethic in Your Kids 54:23 How to Handle Losses 56:06 Chandler vs Charles Oliveira 2 BREAKDOWN 1:01:08 Chandler's Alter Ego 1:03:09 Chandler's Tequila Company 1:06:32 DJ's Experience with Edibles 1:10:08 Shoutout 1st Phorm! 1:10:38 Chandler's Thoughts on Bo Nickal 1:12:46 Jon Jones vs Stipe Miocic BREAKDOWN 1:14:05 Chandler's Nutrition Plan 1:16:23 Chandler has Competed at 155 for 20 YEARS… 1:17:05 How to Support Chandler 1:17:47 Ariel Helwani Set Up the Pod?! 1:18:47 DJ Praises Chandler 1:20:23 Mighty Recap! 1:21:02 DJ Reacts to Chandler's Time Off 1:23:09 Chandler Gets WAY Too Much Hate 1:29:34 McGregor's Anti-Wrestling Comments REACTION 1:31:33 Thoughts on UFC 309 1:32:42 DJ Doesn't Need to See Aspinall vs Jones? 1:35:52 Ranking the MMA Heavyweight Champs (Ngannou, Aspinall, and Jones) 1:37:21 Jones is Not One of the BEST Heavyweights Ever? Produced/Edited by Michael Wonsover (@mwonsover on IG/Twitter) Edited by Nick Pappas (@nick_pappas44 on IG)

Albeit for very different reasons, we've been looking forward to both Jon Jones vs. Stipe Miocic and Mike Tyson vs. Jake Paul for a while now. Both fights have experienced lengthy delays (one owing to Jones' torn pectoral, the other owing to Tyson “vomiting blood and defecating tar” on an airplane) and now they are going to share a single weekend. The spectacle that will be Tyson vs. Paul airs Friday night on Netflix, and perhaps even more than the fight itself, we're keen to see what the reaction will be on that platform. Jones and Miocic do the damn thing for the UFC heavyweight title the next night from Madison Square Garden in the main event of UFC 309. It'll be Jones' second foray into the big boy division, while Miocic returns for the first time since 2021. What will happen? Well, oddsmakers think they know. Is there any chance we might be surprised? Learn more about your ad choices. Visit megaphone.fm/adchoices

Sean and Graeme talk Jones vs. Stipe, Reug Reug, Oktagon, Prates, McGregor trial and more! And now….. here's the podcast!

Jason “Mayhem” Miller and Adam Carolla return to the audio octagon to discuss the week's latest mixed-martial arts news, including a potential “last dance” for Dustin Poirier, Conor McgGregor's legal troubles, what Chael Sonnen thinks Stipe has going for him against Jon Jones, and which fighter Tom Aspinall thinks could replace Dana White.

IS BO NICKAL THE FUTURE OF UFC?! On the latest episode of "MightyCast", Demetrious Johnson is joined by 3x NCAA champ & UFC top prospect Bo Nickal! Check Out Bo's Channel!  @nobickal1  If you're +21, try VIIA Hemp today and use code MIGHTY to save 15% https://bit.ly/viiamighty 0:00 Intro 0:57 Welcome Bo Nickal! 1:35 Bo is an ELITE Wrestler 2:34 Bo's Intro to Wrestling (Wrestling Prodigy) 6:57 Bo was Forced to Wrestle? 10:31 Going All In on Wrestling 12:49 VIIA Hemp! 14:05 The Importance of Playing Multiple Sports as a Kid 15:41 Did Bo Want to Go to the Olympics? 17:37 Bo's Dad Coaches Him?! 20:19 Hardest Part of the Transition from Wrestling to MMA 22:39 ATT Built Bo a Gym?! 26:16 Gordon Ryan vs Bo BREAKDOWN 31:51 MMA Fighters are Lazy? 33:27 Bo only had 1 Pro Fight Before the UFC?! 34:34 The Best Base for MMA 35:18 Bo's First Pro Fight 37:21 Winning TWICE on DWCS 39:09 Why Doesn't Bo Fight Very Often? 45:58 Bo's ELITE Training and Recovery Routines 49:03 Bo's UNIQUE Stretching Routine 52:17 Paul Craig vs Bo BREAKDOWN 57:22 Jon Jones vs Stipe Miocic BREAKDOWN 58:58 Intelligence in MMA is UNDERRATED 1:03:50 Where to Follow Bo 1:04:44 Bo is a New Father 1:08:35 Bo Got Paid by Penn State After College?! 1:13:09 Mighty Recap! 1:13:21 Bo is a True Competitor 1:14:54 Coaching Your Kids is HARD 1:15:35 DJ Reacts to Bo Taking Big Gaps Between Fights 1:16:19 Bo Nickal vs Paul Craig BREAKDOWN 1:18:21 Bo and DJ's Off-Air Conversation 1:19:55 Can Bo Become Champ at 185? Produced/Edited by Michael Wonsover (@mwonsover on IG/Twitter) Edited by Nick Pappas (@nick_pappas44 on IG) ⚡️ PrizePicks: Sign up with code "MIGHTYCAST" to play $5 and WIN $50 INSTANTLY https://prizepicks.onelink.me/ivHR/MIGHTYCAST If you're +21, try VIIA Hemp today and use code MIGHTY to save 15% https://bit.ly/viiamighty ⚡️ 1st Phorm: Check out 1st Phorm at https://1stphorm.com/mightycast ★ Merch: https://shopmighty.com ♦ Twitter: https://twitter.com/mightymouse/ ♦ Instagram: https://www.instagram.com/mighty/ ♦ Discord: https://discord.gg/mightysquad ♦ My Quantum Bars: https://quantumsquares.com/ Promo Code: MIGHTYGAMING10 ♦ My Cold Therapy: https://icebarrel.com/ Promo Code: MIGHTY

Where is Ryan Bader?! - FIS Ep.193 ft. PFL Heavyweight Daniel James "The American Predator"Daniel James TELLS ALL in this incredible interview, which details his recent USADA suspension, the PFL and Bellator's (mis) management of the situation, Timmy B's conspiracy theory around the whole thing (which is spot on), AND get a SNEAK PEEK at how Stipe's training is going, with the American Predator, ahead of #UFC309!PLUS: Ringside Raine and Timmy B discuss the bizarre flyweight title fight against a relative unknown at #UFC310 in lieu of fighting ANY ranked UFC flyweight?!?! Make it make sense, Dana!Get our merch at https://millions.co/fight-in-sight ! Look cooler than you do now.For sponsorship opportunities, to purchase our shirt/tank top, or to find out how you can be a guest on the show, please email us at fightinsightpod@gmail.comFinally, and most importantly, please follow, subscribe, leave a 5-star rating, and tell your friends about us!Guest LinksConnect with Ringside Raine: Instagram: https://www.instagram.com/ringsideraine/Connect with Daniel: Instagram: https://www.instagram.com/danieljames_predator/Follow Fight In SightFIGHT IN SIGHT IG: https://www.instagram.com/fightinsightpodcast/FIGHT IN SIGHT YouTube: https://www.youtube.com/channel/UC8ZW2w0va-VWeep_JtlhAjQExplore more from the Rage Works Podcast Network: https://www.rageworksnetwork.com/The views expressed on air during the Fight In Sight Podcast do not represent the views of the RAGE Works staff, partners, or affiliates. Listener discretion is advised.

Dr. Ryan Augustin and Dr. Jason Luke discuss neoadjuvant immunotherapy and the importance of multidisciplinary team coordination, promising new TIL therapy for advanced melanoma, and the emerging role of CD3 engagers in treatment strategies. TRANSCRIPT Dr. Ryan Augustin: Hello, I'm Dr. Ryan Augustin, your guest host of the ASCO Daily News Podcast today. I'm a medical oncology fellow at Mayo Clinic in Rochester, Minnesota. Joining me today is Dr. Jason Luke, an associate professor of medicine and the director of the Cancer Immunotherapeutic Center at the University of Pittsburgh Hillman Cancer Center. I had the privilege of working as a postdoc in Jason's translational bioinformatics lab, where we investigated mechanisms of resistance to immunotherapy in melanoma and other cancers.  Today, we'll be discussing 3 important topics, including neoadjuvant immunotherapy and the importance of multidisciplinary team coordination, the impact and practical considerations for incorporating TIL therapy into melanoma, and the current and future use of CD3 engagers in both uveal and cutaneous melanoma.  You'll find our full disclosures in the transcript of this episode.  Jason, it's great to have this opportunity to speak with you today. Dr. Jason Luke: Absolutely. Thanks, Ryan. It's great to see you. Dr. Ryan Augustin: So, to kick things off, Jason, we, of course, have seen tremendous advances in cancer immunotherapy, not only in metastatic disease but also the perioperative setting. Recent data have shown that the use of neoadjuvant therapy can provide not only critical prognostic information but can also help individualize post-resection treatment strategies and potentially even eliminate adjuvant therapy altogether in patients who achieve a pathologic, complete response. This signifies a conceptual shift in oncology with the goal of curing patients with immunotherapy. In triple-negative breast cancer, the KEYNOTE-522 regimen with pembrolizumab is standard of care. In non-small cell lung cancer, there are now four FDA approved chemo-IO regimens in both the neoadjuvant and perioperative settings. And, of course, in melanoma, starting with SWOG S1801 utilizing pembro mono therapy, and now with combined CTLA-4 PD-1 blockade based on results from the NADINA trial, neoadjuvant IO is the new standard of care in high-risk, resectable melanoma. It's important to highlight this because whereas other tumor types have more mature multidisciplinary care, for example, patients with breast cancer are reviewed by the whole team in every center, and every patient with lung cancer certainly benefits from multidisciplinary care conferences, that's not always the case with melanoma, given the relative frequency of cases compared to other tumor types.  Jason, would you say that we have now moved into an era where the integration of a multidisciplinary team and melanoma needs to be prioritized. And why is it important to have multidisciplinary team coordination from the onset of a patient's diagnosis? Dr. Jason Luke: Well, I think those are great questions, Ryan, and I think they really speak to the movement in our field and the great success that we've had integrating systemic therapy, particularly immunotherapy, into our treatment paradigms. And so, before answering your question directly, I would add even a little bit more color, which is to note that over the last few years, we've additionally seen the development of adjuvant therapy into stages of melanoma that, historically speaking, were considered low-risk, and medical oncologists might not even see the patient. To that, I'm speaking specifically about the stage 2B and 2C approvals for adjuvant anti-PD-1 with pembrolizumab or nivolumab. So this has been an emerging complication.  Classically, patients are diagnosed with melanoma by either their primary care doctor or a dermatologist. Again, classically, the next step was referral to a surgeon who had removed the primary lesion, with discussion around nodal evaluation as well. And that paradigm has really changed now, where I think integration of medical oncology input early on in the evaluation of the appropriate treatment plan for patients with melanoma is quite a pressing issue now, both because we have FDA approvals for therapeutics that can reduce risk of recurrence, and whether or not to pursue those makes a big difference to the patient for discussion early on.  And, moreover, the use of systemic therapies now, prior to surgery, of course, then, of course, requires the involvement of medical oncology. And just for an emphasis point on this, it's classically the case, for good reason, that surgeons complete their surgery and then feel confident to tell the patient, “Well, we got it all, and you're just in really good shape.” And while I understand where that's coming from, that often leaves aside the risk of recurrence. So you can have the most perfect surgery in the world and yet still be at very high risk of recurrence. And so it's commonly the case that we get patients referred to us after surgery who think they're just in totally good shape, quite surprised to find out that, in fact, they might have a 20% to 50% risk of recurrence. And so that's where this multidisciplinary integration for patient management really does make a big difference.  And so I would really emphasize the point you were making before, which is that we need multidisciplinary teams of med onc with derm, with surgery early on, to discuss “What are the treatment plans going to be for patients?” And that's true for neoadjuvant therapy, so, for palpable stage 3, where we might give checkpoint inhibitors or combinations before surgery. But it's true even in any reasonably high-risk melanoma, and I would argue in that state, anything more than stage 1 should be discussed as a group, because that communication strategy with the patient is so important from first principles, so that they have an expectation of what it's going to look like as they are followed out over time. And so we're emphasizing this point because I think it's mostly the case at most hospitals that there isn't a cutaneous oncology disease management meeting, and I think there needs to be.  It's important to point out that usually the surgeons that do this kind of surgery are actually either the GI surgeons who do colon cancer or the breast surgeons. And so, given that melanoma, it's not the most common kind of cancer, it could easily be integrated into the existing disease review groups to review these cases. And I think that's the point we really want to emphasize now. I think we're not going to belabor the data so much, but there are enormous advantages to either perioperative or adjuvant systemic therapy in melanoma. We're talking about risk reduction of more than 50%, 50-75% risk reduction. It's essential that we make sure we optimally offer that to patients. And, of course, patients will choose what they think is best for their care. But we need to message to them in a way that they can understand what the risks and benefits of those treatments are and then are well set up to understand what that treatment might look like and what their expectations would be out over time.  So I think this is a great art of medicine place to start. Instead of belaboring just the details of the trial to say, let's think about how we take care of our patients and how we communicate with them on first principles so that we can make the most out of the treatments that we do have available. Dr. Ryan Augustin: That's great, Jason. Very insightful points. Thank you.  So, shifting gears now, I'd also like to ask you a little bit about TIL therapy in melanoma. So our listeners will be aware that TIL is a promising new approach for treating advanced melanoma and leverages the power of a patient's cytotoxic T cells to attack cancer cells. While we've known about the potential of this therapy for some time, based on pioneering work at the NCI, this therapy is now FDA approved under the brand AMTAGVI (Lifileucel) from Iovance Biotherapeutics, making it the first cellular therapy to be approved for a solid tumor. Now, I know TIL therapy has been administered at your institution, Jason, for several years now, under trial status primarily for uveal melanoma using an in-house processing. But for many cancer centers, the only experience with cellular therapy has come under the domain of malignant hematology with CAR T administration. At our institution, for example, we have only recently started administering TIL therapy for melanoma, which has required a tremendous multidisciplinary effort among outpatient oncology, critical care, and an inpatient hematology service that has expertise in cytokine release syndrome.  Jason, where do you see TIL therapy fitting into the metastatic space? Which patients do you think are truly candidates for this intensive therapy? And what other practical or logistical considerations do you think we should keep in mind moving forward? Dr. Jason Luke: Well, thanks for raising this. I think the approval of lifileucel, which is the scientific name for the TIL product that's on the market now. It really is a shift, a landscape shift in oncology, and we're starting in melanoma again, as seems to be commonly the case in drug development. But it's really important to understand that this is a conceptually different kind of treatment, and therefore, it does require different considerations. Starting first with data and then actualization, maybe secondarily, when we see across the accelerated approval package that led to this being available, we quote patients that the response rate is likely in the range of 30%, maybe slightly lower than that, but a meaningful 25% to 30% response rate, and that most of those patients that do have response, it seems to be quite durable, meaning patients have been followed up to four years, and almost all the responders are still in response. And that's a really powerful thing to be able to tell a patient, particularly if the patient has already proceeded through multiple lines of prior standard therapy. So this is a very, very promising therapy.  Now, it is a complicated therapy as well. And so you highlighted that to do this, you have to have a tumor that's amenable for resection, a multidisciplinary team that has done a surgery to remove the tumor, sent it off to the company. They then need to process the TIL out of the tumor and then build them up into a personalized cell product, bring it back, you have to lympho-deplete the patient, re-introduce this TIL. So this is a process that, in the standard of care setting under best circumstances, takes roughly six weeks. So how to get that done in a timely fashion, I think, is evolving within our paradigms. But I think it is very important for people who practice in settings where this isn't already available to realize that referring patients for this should be a strong consideration. And thinking about how you could build your multidisciplinary team in a way to be able to facilitate this process, I think is going to be important, because this concept of TIL is relevant to other solid tumors as well. It's not approved yet in others, but we kind of assume eventually it probably will be. And so I think, thinking through this, how could it work, how do you refer patients is very important.  Now, coming back to the science, who should we treat with this? Well, of course, it's now an air quotes “standard of care option”, so really it ought to be available to anybody. I will note that currently, the capacity across the country to make these products is not really adequate to treat all the patients that we'd want. But who would we optimally want to treat, of course, would be people who have retained a good performance status after first line therapy, people who have tumors that are easily removable and who have not manifested a really rapid disease progression course, because then, of course, that six-week timeline probably doesn't make sense. The other really interesting data point out of the clinical trials so far is it has looked like the patients who got the least amount of benefit from anti-PD-1 immunotherapy, in other words, who progressed immediately without any kind of sustained response, those patients seem to have the best response to TILs, and that's actually sort of a great biomarker. So, this drug works the best for the population of patients where checkpoint inhibitors were not effective. And so as you think about who those patients might be in your practice, as you're listening, I think prioritizing it for primary progression on anti PD-1, again and giving it ahead thought about how would you get the patient through this process or referred to this process very quickly is really important because that lag time is a problem. Patients who have melanoma tend to progress reasonably quickly, and six weeks can be a long time in melanoma land. So, thinking ahead and building those processes is going to be important moving into the future Dr. Ryan Augustin: Definitely appreciate those practical considerations. Jason, thank you.  Moving on to our final topic, I was hoping to discuss the use of immune cell engagers in melanoma. So, similar to CAR T therapy, bispecific T-cell engagers, or BiTEs, as they're commonly known, are standard of care in refractory myeloma and lymphoma. But these antibodies engaging CD-3 on T cells and a tumor specific antigen on cancer cells are relatively new in the solid tumor space. Tarlatamab, which is a DLL-3 and CD-3 bispecific antibody, was recently approved in refractory small cell lung cancer, and, of course, tebentafusp, an HLA-directed CD-3 T cell engager was approved in uveal melanoma in 2022. Both T and NK cell engaging therapies are now offering hope in cancers where there has historically been little to offer. However, similar to our discussion with TIL therapy, bispecifics can lead to CRS and neurotoxicity, which require considerable logistical support and care coordination.  Jason, I was wondering if you could briefly discuss the current landscape of immune cell engagers in melanoma and how soon we may see these therapies enter the treatment paradigm for cutaneous disease. Dr. Jason Luke: I think it is an exciting, novel treatment strategy that I think we will only see emerge more and more. You alluded to the approval of tebentafusp in uveal melanoma, and those trials were, over the course of a decade, where those of us in solid tumor land learned how to manage cytokine release syndrome or the impact of these C3 bispecifics, in a way that we weren't used to. And what I'll caution people is that CRS, as this term, it sounds very scary because people have heard of patients that, of course, had difficult outcomes and hematological malignancies, but it's a spectrum of side effects. And so, when we think about tebentafusp, which is the approved molecule, really what we see is a lot of rash because GP100, the other tumor antigen target, is in the skin. So, patients get a rash, and then people do get fevers, but it's pretty rare to get more than that. So really what you have to have is the capacity to monitor patients for 12 hours, but it's really not more scary than that. So it really just requires treating a few people to kind of get used to these kinds of symptoms, because they're not the full-on ICU level CRS that we see with, say, CAR T-cells.  But where is the field going? Well, there's a second CD3 bispecific called brenetafusp that targets the molecule PRAME, that's in a phase 3 clinical trial now for frontline cutaneous melanoma. And tebentafusp is also being evaluated in cutaneous melanoma for refractory disease. So, it's very possible that these could be very commonly used for cutaneous melanoma, moving into, say, a two-to-four-year time horizon. And so therefore, getting used to what are these side effects, how do you manage them in an ambulatory practice for solid tumor, etc., is going to be something everyone's going to have to learn how to deal with, but I don't think it should be something that people should be afraid of.  One thing that we've seen with these molecules so far is that their kinetics of treatment effect do look slightly different than what we see with more classic oncology therapies. These drugs have a long-term benefit but doesn't always manifest as disease regression. So, we commonly see patients will have stable disease, meaning their tumor stops growing, but we don't see that it shrank a lot, but that can turn into a very meaningful long-term benefit. So that's something that we're also, as a community, going to have to get used to. It may not be the case we see tumors shrink dramatically upfront, but rather we can actually follow people with good quality- of-life over a longer period of time.  Where is the field going? You mentioned tarlatamab in small cell lung cancer, and I think we're only going to see more of these as appropriate tumor antigens are identified in different tumors. And then the other piece is these CD3 engagers generally rely upon some kind of engagement with a T cell, whether CD3 engagers, and so they can be TCR or T-cell receptor-based therapies, although they can be also SCFV-based. But that then requires new biomarkers, because TCR therapy requires HLA restriction. So, understanding that now we're going to need to profile patients based on their germline in addition to the genomics of the tumor. And those two things are separate. But I would argue at this point, basically everybody with cutaneous melanoma should be being profiled for HLA-A(*)0201, which is the major T-cell receptor HLA haplotype that we would be looking for, because whether or not you can get access immediately to tebentafusp, but therefore clinical trials will become more and more important.  Finally, in that T-cell receptor vein, there are also T cell receptor-transduced T cells, which are also becoming of relevance in the oncology community and people listening will be aware in synovial sarcoma of the first approval for a TCR-transduced T cell with afamitresgene autoleucel. And in melanoma, we similarly have TCR-transduced T cells that are coming forward in clinical trials into phase 3, the IMA203 PRAME-directed molecule particularly. And leveraging our prior conversation about TILs, we're going to have more and more cellular based therapies coming forward, which is going to make it important to understand what are the biomarkers that go with those, what are the side effect profiles of these, and how do you build your practice in a way that you can optimally get your patients access to all of these different treatments, because it will become more logistically complicated, kind of as more of these therapies come online over the next, like we said, two to four years kind of time horizon. So, it's very exciting, but there is more to do, both logistically and scientifically. Dr. Ryan Augustin: That's excellent. Thanks, Jason, and thank you so much for sharing your great insight with us today on the ASCO Daily News Podcast. Dr. Jason Luke: Thanks so much for the opportunity. Dr. Ryan Augustin: And thank you to our listeners for your time today. You will find links to the abstracts discussed today in the transcript of this episode, and you can follow Dr. Luke on X, formerly known as Twitter, @jasonlukemd. And you can find me, @RyanAugustinMD. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Follow today's speakers: @ryanaugustinmd Dr. Jason Luke @jasonlukemd   Follow ASCO on social media: @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn   Disclosures: Dr. Ryan Augustin: No relationships to disclose Dr. Jason Luke: Stock and Other Ownership Interests: Actym Therapeutics, Mavu Pharmaceutical, Pyxis, Alphamab Oncology, Tempest Therapeutics, Kanaph Therapeutics, Onc.AI, Arch Oncology, Stipe, NeoTX Consulting or Advisory Role: Bristol-Myers Squibb, Merck, EMD Serono, Novartis, 7 Hills Pharma, Janssen, Reflexion Medical, Tempest Therapeutics, Alphamab Oncology, Spring Bank, Abbvie, Astellas Pharma, Bayer, Incyte, Mersana, Partner Therapeutics, Synlogic, Eisai, Werewolf, Ribon Therapeutics, Checkmate Pharmaceuticals, CStone Pharmaceuticals, Nektar, Regeneron, Rubius, Tesaro, Xilio, Xencor, Alnylam, Crown Bioscience, Flame Biosciences, Genentech, Kadmon, KSQ Therapeutics, Immunocore, Inzen, Pfizer, Silicon Therapeutics, TRex Bio, Bright Peak, Onc.AI, STipe, Codiak Biosciences, Day One Therapeutics, Endeavor, Gilead Sciences, Hotspot Therapeutics, SERVIER, STINGthera, Synthekine Research Funding (Inst.): Merck , Bristol-Myers Squibb, Incyte, Corvus Pharmaceuticals, Abbvie, Macrogenics, Xencor, Array BioPharma, Agios, Astellas Pharma , EMD Serono, Immatics, Kadmon, Moderna Therapeutics, Nektar, Spring bank, Trishula, KAHR Medical, Fstar, Genmab, Ikena Oncology, Numab, Replimmune, Rubius Therapeutics, Synlogic, Takeda, Tizona Therapeutics, Inc., BioNTech AG, Scholar Rock, Next Cure Patents, Royalties, Other Intellectual Property: Serial #15/612,657 (Cancer Immunotherapy), and Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof) Travel, Accommodations, Expenses: Bristol-Myers Squibb, Array BioPharma, EMD Serono, Janssen, Merck, Novartis, Reflexion Medical, Mersana, Pyxis, Xilio

The Big Mates discuss retrofuturism, The Amazing Spider-man, rude dealers, and Up by R.E.M.Adam, Steve, and Lucas continue their deep dive into the career and discography of R.E.M. by continuing their analysis of the band's eleventh studio album, released in 1998. They talk about the writing and recording process, the context surrounding the songs, and offer up analysis, opinions, and thoughts from three differing perspectives on music, from being deeply into analysis and music, to not caring for art or critique, and everything in between.They pick up their discussion near the beginning of the album and continue their trakc-by-track analysis, discussing mood, tone, co-writing credits, Stipe's new way of writing, and the band's goal of being "fearless."How far into the album will they get? How many Christmas songs are on the album? What have horses got to do with Westerns? Find out on this episode of What Is Music?Our next episode is out on Monday October 28th and will conclude our analysis of Up!Join the conversation on:Twitter: https://twitter.com/whatismusicpodInstagram: https://www.instagram.com/whatismusicpodE-mail: whatismusicpod@gmail.comGet access to more shows, exclusive bonus content, ad-free episodes of this show, and more music discussion by subscribing to our Patreon!Head to patreon.com/whatismusicpod and receive up to two new episodes of our various shows every week (including shows about Manic Street Preachers and monthly themed playlists!), ad-free archives of What Is Music?, and access to our Patron-only Discord server for even more music (and non-music) discussion!Support our show when starting your own podcast!By signing up to Buzzsprout with this link: https://www.buzzsprout.com/?referrer_id=780379Check out our merch!https://whatismusicpod.redbubble.comDonate to our podcast!https://ko-fi.com/whatismusichttp://whatismusic.buzzsprout.com/Support the show

Make sure to subscribe and follow the show for new weekly episodes every Thursday!Thank you UnderDog Fantasy for sponsoring the show. All week long Underdog is dropping daily promos for players to cash in on. And all new users can receive up to $1,000 in bonus cash on their first deposit. Support the show, use Code "P4P" when signing up https://play.underdogfantasy.com/p-pound4-poundDaniel Cormier in the studio this week. In a one sentence summary: DC is an all around great human being. He, Kamaru and Henry have a long history, and this hour-long conversation shows you just how much shared respect these three champions have for one another. The guys hit it all in this one. DC's time as an NCAA and Olympic force, and the inspiration he was for budding fighters...Henry Cejudo and Kamaru Usman included. The Cael Sanderson rivalry, or lack thereof, as DC might say. DC's perspective on missing the 2008 Olympics and how it changed his life forever. Deeper on that subject, how does luck, motivation and preparation come together to breed success.How does showmanship and celebrity change fighter trajectory in the UFC? Speaking of celebrity: Jon Jones. DC discusses the impact that the 'baddest man on earth' (Dana's words) had on his career, we talk Jones' upcoming fight against Stipe, and where the reigning reigning Heavyweight champ sits among global athlete superstars. DC's palpable friendliness and positivity is even more appreciated when you understand the hardships he carries with him. He opens up about the loss of his daughter, and the mindset and compartmentalization necessary for surviving the heaviest of losses. Humans at DC's level have a special drive that never fully leaves them. He shares how that drive for growth has translated into life beyond the octagon. We close this one with some much deserved words of appreciation from Kamaru and Henry - and from all of us fight fans. Thank you, DC. Enjoy! 00:00 - Intro3:00 - Uncle DC6:30 - NCAA and Olympics10:40 - DC inspires young Kamaru16:20 - Fake Drugs, Bad Business20:00 - Cael Sanderson23:50 - Great Circumstances26:20 - Tall Guys Fall Harder33:00 - Public Persona41:30 - Jon Jones Rivalry 45:10 - Jon Jones = MJ???48:30 - Words for Francis51:20 - Brotherly Love 56:00 - What drives DC1:01:30 - Flowers for DCMake sure to subscribe and follow the show for new weekly episodes.Follow the Show on SocialInstagram:https://www.instagram.com/pound4pound/Twitter/X:https://twitter.com/Pound4poundshowTik Tok:https://www.tiktok.com/@pound4pound.podca?is_from_webapp=1&sender_device=pcA Shadow Lion Production.

On this episode of Good Guy / Bad Guy…It's official! Jon Jones will take on Stipe Miocic for the Heavyweight Title at Madison Square Garden this November. But this could likely be the last fight for both fighters. Does that mean they're afraid to lose to Interim Heavyweight Champ Tom Aspinall? Well, one of our guys seem to believe so. Plus, Dana White drops a bombshell that Charles Oliveira is next for Michael Chandler and NOT Conor McGregor. Is this a smart move for Michael Chandler and is it a wrap for Conor McGregor inside the octagon? And, DC visited Merab Dvalishvili at his home following his massive win over Sean O'Malley and explains why he really is “The Machine”. Learn more about your ad choices. Visit megaphone.fm/adchoices

Michael Bisping and Anthony Smith discuss all the action at UFC 305 from Dricus digging deep to find a submission win to what's next for Israel Adesanya, Alex Pereira offering to come back down to 185 to finish what Izzy started, Dan Hooker breaking back into the top 5, the controversial scorecard from the Jairzinho Rozenstruik vs Tai Tuiavasa fight before being joined by Brendan Loughnane to talk his upcoming PFL Semi-Final fight this weekend, what it was like growing up on the mean streets of Manchester, how long he plans to keep fighting and more then Tom Aspinall joins the show to talk his big win at UFC 304, why Jon Jones suddenly stopped saying his name, why he believes neither Jones nor Stipe will ever fight him and more plus Poatan vs Khalil Rountree at UFC 307, Brendan Allen and Marvin Vettori kicking off in a casino and so much more!This Episode Was Recorded On 08.19.24Support Our SponsorseBay Motors - http://ebaymotors.com Keep your ride-or-die alive with Ebay Motors!Mando - https://www.ShopMando.com get $5 off your Starter Pack (that's over 40% off) with promo code Bisping!Viia - https://viiahemp.com/ Use code Believe to get 15% off the rest you deserve!Believe You Me is available for early pre release on GaS Digital Network every Monday. Sign-up with code BYM to get access to the archives, bonus content and more! https://gasdigital.com/Follow the show on social media:Twitter: https://twitter.com/BYMPodSubscribe on YouTube: https://bit.ly/3drq6psFollow the hosts on social:Michael Bisping Twitter https://twitter.com/bispingMichael Bisping Instagram https://www.instagram.com/mikebisping/Michael Bisping YouTube https://www.youtube.com/channel/UCDrG2_1TcVkXKXXsD6KjwigWebsite https://gasdigitalnetwork.com/gdn-show-channels/believe-you-me/Anthony Smith Twitter: https://twitter.com/lionheartasmithAnthony Smith Instagram: https://www.instagram.com/lionheartasmith/Mike's debut book "Quitters Never Win" is available wherever books are sold, click here to get a copy! https://bit.ly/2V9ZqDkFollow The Guests On SocialTom Apinall Twitter: https://twitter.com/AspinallMMATom Apinall Instagram: https://www.instagram.com/tomaspinallofficialBrendan Loughnane Twitter: https://twitter.com/BrendanMMABrendan Loughnane Instagram: https://www.instagram.com/brendanmmaFollow the team on social:Brian MacKay Instagram: https://www.instagram.com/bmackayisrightBrian MacKay Twitter: https://twitter.com/bmackayisrightMike Harrington Twitter: https://twitter.com/TheMHarringtonMike Harrington Instagram https://www.instagram.com/themharringtonMike Harrington YouTube: https://www.youtube.com/@themharringtonBelieve You Me is a twice weekly podcast covering MMA news in a comedy podcast format hosted by former UFC Middleweight Champion Michael Bisping.Michael Bisping is a Former UFC Middleweight Champion. He transitioned to commentary in his post fight career and regularly calls the biggest fights. In addition to analyst work Michael has been cast in shows on Netflix, CBS and Showtime and has appeared in movies such as XXX: Return of Xander Cage, Den Of Thieves and Triple Threat. His next project slated for release is Warrior on Netflix in October, his self titled documentary "Bisping" is out now and just made #1 on the US and UK charts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Michael Bisping and Anthony Smith talk UFC 305 fight week being here and all the storylines surrounding it from Israel Adesanya's much anticipated return to DDP getting tasered by his coach and saying Sean Strickland is going to be on the sidelines for a long time if he waits for a title shot, Merab taking aim at Tim Welch, the update to the unified rules of MMA to allow 12-6 Elbows, Tom Aspinall calling for Stipe to get the Joe Biden treatment and so much more!This Episode Was Recorded On 08.12.24Support Our SponsorsBetter Help - This episode is sponsored by Better Help. Visit https://www.betterhelp.com/Believe today to get 10% off your first month.eBay Motors - http://ebaymotors.com Keep your ride-or-die alive with Ebay Motors!Fit Bod - https://Fitbod.me/BELIEVE Click the link to sign up and get 25% off your subscription or try out the app for FREE True Nutrition - Truenutrition.com/believe Take the guesswork out of nutrition and get 15% off with code BelieveFollow the show on social media:Twitter: https://twitter.com/BYMPodSubscribe on YouTube: https://bit.ly/3drq6psFollow the hosts on social:Michael Bisping Twitter https://twitter.com/bispingMichael Bisping Instagram https://www.instagram.com/mikebisping/Michael Bisping YouTube https://www.youtube.com/channel/UCDrG2_1TcVkXKXXsD6KjwigWebsite https://gasdigitalnetwork.com/gdn-show-channels/believe-you-me/Anthony Smith Twitter: https://twitter.com/lionheartasmithAnthony Smith Instagram: https://www.instagram.com/lionheartasmith/Mike's debut book "Quitters Never Win" is available wherever books are sold, click here to get a copy! https://bit.ly/2V9ZqDkFollow the team on social:Brian MacKay Instagram: https://www.instagram.com/bmackayisrightBrian MacKay Twitter: https://twitter.com/bmackayisrightMike Harrington Twitter: https://twitter.com/TheMHarringtonMike Harrington Instagram https://www.instagram.com/themharringtonMike Harrington YouTube: https://www.youtube.com/@themharringtonBelieve You Me is a twice weekly podcast covering MMA news in a comedy podcast format hosted by former UFC Middleweight Champion Michael Bisping.Michael Bisping is a Former UFC Middleweight Champion. He transitioned to commentary in his post fight career and regularly calls the biggest fights. In addition to analyst work Michael has been cast in shows on Netflix, CBS and Showtime and has appeared in movies such as XXX: Return of Xander Cage, Den Of Thieves and Triple Threat. His next project slated for release is Warrior on Netflix in October, his self titled documentary "Bisping" is out now and just made #1 on the US and UK charts.“To advertise your product on GaS Digital podcasts please email jimmy@gasdigitalmarketing.com with a brief description about your product and any shows you may be interested in advertising on”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The UFC this week made good on its promise to book a men's featherweight title fight between Ilia Topuria and Max Holloway and we … are … stoked. For hardcore fans, this might be the best fight available right now (if we're really going through with Jones vs. Stipe instead of Jones vs. Aspinall) and actually getting it is cause for celebration. It's going down at UFC 308 in October. Only question is, will Holloway's BMF belt be on the line, too, or are we finally admitting the BMF title is just some shit we hand out to whoever, whenever it fits our needs? Plus, Dana White would like us to believe the judge denying the settlement in the UFC antitrust lawsuit is rooted in some high school bullshit and Conor McGregor showed up to cosplay at Stugis of all goddamned places. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nate Diaz and Jorge Masvidal wrote the second chapter of their combat sports rivalry this past Saturday night in the boxing ring. This time, Diaz got the victory over Masvidal in a very fun 10-rounder. How do you grade the fight between one-time UFC competitors, and what is next for both guys? On an all-new edition of Between the Links, the MMA Fighting panel reacts to the Diaz vs. Masvidal fight, if a third meeting should be next, and how likely Diaz and Masvidal's next fights will be in the UFC. Additionally, topics include this Saturday's UFC Denver event, the headliner between former champ Rose Namajunas and Tracy Cortez and the stakes for both women, other must-see bouts on the card, Jon Jones and Stipe Miocic continuing to defend their potential fight, Darren Till's boxing debut, and more. Host Mike Heck moderates the matchup between MMA Fighting's Jed Meshew and Alexander K. Lee.  Follow Mike Heck: @MikeHeck_JR Follow Jed Meshew: @JedKMeshew Follow Alexander K. Lee: @AlexanderKLee Subscribe to MMA Fighting Check out our full video catalog Like MMA Fighting on Facebook Follow on Twitter Read More: http://www.mmafighting.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Well, you know what they say about sunshine and the proverbial dog's ass. Hard to believe, but Nate Diaz and Jorge Masvidal went out there and had an (allegedly) entertaining boxing match over the weekend. We guess the law of averages says it was bound to happen eventually. Question is, though, now that we're this far down the road into the overwhelmingly disappointing “old MMA guys try to box” period of our declining society, did anybody watch? Plus, Jon Jones says he and Stipe finally have something on the books and Reug Reug wins a fight against a guy named Ketchup that was even more ridiculous than it sounds. Learn more about your ad choices. Visit megaphone.fm/adchoices

Michael Bisping and Anthony Smith discuss Anthony's big win at UFC 301 over Vitor Petrino, responding to getting called out for a submission challenge by Alex Pereira getting offered a super quick turn around fight and more plus a breakdown of Jose Aldo's triumphant return and the rest of the fights on the card, Conor calling out Ryan Garcia and Sean O'Malley for PED use, Jon Jones teasing a fight against Alex Periera instead of Tom Aspinall if all goes right in the Stipe fight, Big Tom's response and so much more!This Episode Was Recorded On 05.07.24Support Our SponsorsBetter Help - This episode is sponsored by Better Help. Visit https://www.BetterHelp.com/Believe today to get 10% off your first month.Eight Sleep - eightsleep.com/bisping Click The Link and get $200 off plus free shipping on the Pod CoverMando - https://www.ShopMando.com get $5 off your Starter Pack (that's over 40% off) with promo code Bisping!Believe You Me is available for early pre release on GaS Digital Network every Monday. Sign-up with code BYM to get access to the archives, bonus content and more! https://gasdigital.com/"Free Cain" Shirts Herehttps://derekbrunson.com/collections/mensFollow the show on social media:Twitter: https://twitter.com/BYMPodSubscribe on YouTube: https://bit.ly/3drq6psFollow the hosts on social:Michael Bisping Twitter https://twitter.com/bispingMichael Bisping Instagram https://www.instagram.com/mikebisping/Michael Bisping YouTube https://www.youtube.com/channel/UCDrG2_1TcVkXKXXsD6KjwigWebsite https://gasdigitalnetwork.com/gdn-show-channels/believe-you-me/Anthony Smith Twitter: https://twitter.com/lionheartasmithAnthony Smith Instagram: https://www.instagram.com/lionheartasmith/Mike's debut book "Quitters Never Win" is available wherever books are sold, click here to get a copy! https://bit.ly/2V9ZqDkFollow the team on social:Brian MacKay Instagram: https://www.instagram.com/bmackayisrightBrian MacKay Twitter: https://twitter.com/bmackayisrightMike Harrington Twitter: https://twitter.com/TheMHarringtonMike Harrington Instagram https://www.instagram.com/themharringtonMike Harrington YouTube: https://www.youtube.com/@themharringtonBelieve You Me is a twice weekly podcast covering MMA news in a comedy podcast format hosted by former UFC Middleweight Champion Michael Bisping.Michael Bisping is a Former UFC Middleweight Champion. He transitioned to commentary in his post fight career and regularly calls the biggest fights. In addition to analyst work Michael has been cast in shows on Netflix, CBS and Showtime and has appeared in movies such as XXX: Return of Xander Cage, Den Of Thieves and Triple Threat. His next project slated for release is Warrior on Netflix in October, his self titled documentary "Bisping" is out now and just made #1 on the US and UK charts.“To advertise your product on GaS Digital podcasts please email jimmy@gasdigitalmarketing.com with a brief description about your product and any shows you may be interested in advertising on”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.